GoodRx vs MEDVi
GoodRx costs $100 less a month.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between GoodRx and MEDVi, the first difference is cost: GoodRx is $100 a month cheaper at the entry price. MEDVi leads our six-part score, 7.1 to 6.9. One of the two has an FDA warning letter on record, covered below.
GoodRx vs MEDVi price
GoodRx is the cheaper way in: $149 a month against $249 a month at MEDVi. That is $100 less each month (40% lower), or about $1,200 over a year of treatment.
Medications and formats
GoodRx and MEDVi do not overlap on medication; only GoodRx lists tirzepatide and orforglipron; only MEDVi lists semaglutide.
On format, GoodRx prices brand-name pens, while MEDVi prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, GoodRx is the only one of the two with a brand-name price.
Where each one treats patients
GoodRx lists 50 states, and MEDVi lists 48 states.
They overlap in 48 states. GoodRx alone covers Mississippi and North Dakota.
Pricing
GoodRx
MEDVi
Refills are locked in at $299. The first month is $179 in the 'SUMMER Sale,' and some MEDVi landing pages offer the first month at $149.
Flat 'Starting at $249' — no intro discount shown.
$99 Membership + Medication Cost — medication cost not published (varies/insurance may reimburse). 'Availability is subject to change.'
$99 Membership + Medication Cost — medication cost not published. COMPOUNDED tirzepatide ($349 in our current entry) is no longer published anywhere on glp1.medvi.org, home.medvi.org, or the intake flow (0 mentions) — treat as discontinued/not published, do not carry the $349 row forward.
What each price covers
MEDVi's price also covers the clinician visit, the medication itself, shipping and coaching, which GoodRx does not claim.
GoodRx does not say what its price includes.
MEDVi is silent on lab work.
That matters most for the drug: unless GoodRx confirms otherwise, budget for medication on top of its listed price.
GoodRx
Inclusions not disclosed.
MEDVi
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, MEDVi scores 7.1 and GoodRx 6.9 out of 10.
GoodRx is stronger on value (5.0 vs 2.8).
MEDVi is stronger on user experience (8.0 vs 5.0) and support (8.5 vs 5.0).
Effectiveness, trust & safety and accessibility are within half a point.
GoodRx
6.9/10
MEDVi
7.1/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent MEDVi a warning letter dated February 20, 2026 (letter 721455), and it is still open.
GoodRx has no FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | MEDVi |
|---|---|---|
| Starting Price | ✓$149/mo | $249/mo |
| Features | 6 features | ✓7 features |
| States Available | ✓50 | 48 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About MEDVi
Two clinical groups do the treating at MEDVi: CareGLP Affiliated P.C.s, plus clinicians from OpenLoop Health. Its weight-loss menu holds compounded GLP-1s, injections and tablets alike, the molecule being semaglutide, next to Zepbound and Wegovy under their brand names. Licensed US pharmacies fill all of it.
Read our full MEDVi review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
MEDVi
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits, shipping and coaching
- Serves 48 states
- Names 3 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
- The FDA has issued MEDVi a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
MEDVi wins this one, 7.1 to 6.9, above all for knowing which pharmacy fills the vial: it names Triad Rx. GoodRx undercuts it by $100 a month, so if the monthly bill is what decides it, GoodRx is the pick. GoodRx fits better if oral orforglipron alongside the injectables is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose MEDVi if…
You want knowing which pharmacy fills the vial: it names Triad Rx and an opening price near $249 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →GoodRx vs MEDVi: FAQ
Close alternatives to GoodRx and MEDVi
- GoodRx vs Found
- GoodRx vs Kin Meds
- GoodRx vs PrideRx
- GoodRx vs PreventiveMD
- MEDVi vs Cabana
- MEDVi vs Next Vial
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.